Today: 20 May 2026
Lam Research stock swings lower after early pop as Citi, Deutsche Bank lift targets ahead of earnings
22 January 2026
1 min read

Lam Research stock swings lower after early pop as Citi, Deutsche Bank lift targets ahead of earnings

New York, Jan 22, 2026, 11:35 (ET) — Regular session

  • Shares of Lam Research dropped roughly 2.9% by midday, even after climbing to an early peak of $238.20
  • Citi bumped its price target up to $265, while Deutsche Bank raised theirs to $260. Both firms maintained their Buy ratings.
  • Investors are turning their attention to Lam’s quarterly results on January 28 and its guidance on chip-factory spending ahead.

Lam Research shares slipped 2.9% to $221.88 on Thursday, erasing gains from an earlier surge up to $238.20. The semiconductor equipment company’s stock closed $6.52 lower than Wednesday.

The broader chip tools group stayed steady despite the pullback. The VanEck Semiconductor ETF climbed around 0.7%, and the iShares Semiconductor ETF rose about 0.5%. Applied Materials dropped roughly 1%, KLA barely moved, and ASML gained close to 1.7%.

Why it matters now: Lam’s shares have hovered near recent peaks ahead of a wave of analyst reports and an earnings announcement seen as a key test for the stock. On Wednesday, the stock closed at $228.39—just under 1% shy of its previous 52-week high—while trading volume surged.

Citi lifted its price target on Lam to $265 from $190 on Thursday, maintaining a Buy rating. According to a note cited by TheFly, the bank views Lam as entering a “Phase 2 upcycle,” with wafer fab equipment spending—essentially the tools chipmakers use to produce semiconductors—moving toward Citi’s bullish $126 billion forecast for 2026. TipRanks

Just a day before, Deutsche Bank’s Melissa Weathers raised her price target to $260 from $195, maintaining a Buy rating. She noted the firm had revised its model ahead of earnings and now expects Lam to deliver results “solidly above Street,” referring to consensus analyst estimates. TipRanks

Not all analysts agree. On Thursday, New Street bumped its price target up to $195 from $140 but stuck with a Neutral rating, MT Newswires reports.

Lam, headquartered in Fremont, California, offers etch and deposition equipment essential for chip manufacturing, plus services for its installed machines. The stock’s sudden intraday swing highlights how, as earnings approach, investors are betting not only on current results but also on how 2026 spending will unfold at major chipmakers.

The risk is clear: even solid results might not satisfy investors if the company’s forecast disappoints a market hungry for “upcycle” talk. Signs of delayed orders, pricing pressure, or weaker demand in memory gear could swiftly weigh on the stock.

Lam plans to release its December-quarter earnings on Jan. 28, with a conference call set for 5:00 p.m. Eastern, the company announced.

Traders are zeroing in on what comes next. All eyes will be on management’s insights into wafer-fab spending, the timing of customer deliveries, and whether the recent upbeat analyst forecasts actually make it into the guidance — extending beyond the upcoming quarter’s results.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Natural gas spikes above $5 after EIA storage draw as UNG and LNG-linked stocks swing
Previous Story

Natural gas spikes above $5 after EIA storage draw as UNG and LNG-linked stocks swing

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus
Next Story

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus

Go toTop